
CEO Claude Zdanow details improving operating results, the commercialization of the Company's Cortex technology, a signed non-binding letter of intent for a potentially transformative acquisition, a s
First quarter 2026 revenue increased 39% year-over-year, loss from operations improved 68% and net cash used in operations improved 40%; fiscal year 2025 revenue grew 63% and gross profit returned to